Appeals Panel:  No Jurisdiction Over Nonresident Companies In Amiodarone Cases

(August 4, 2020, 8:59 AM EDT) -- SAN FRANCISCO — Following the U.S. Supreme Court's precedent in another California state court drug case, a California appeals court panel on July 30 ruled that a state court does not have personal jurisdiction over nonresident drug companies in hundreds of cases by out-of-state plaintiffs alleging injuries from off-label marketing of the heart arrythmia drug amiodarone (In re Amiodarone Cases, Nos. A157035, A158160 and A159522, Calif. App., 1st Dist., Div. 2, 2020 Cal. App. Unpub. LEXIS 4874)....

Attached Documents

Related Sections